Evercore ISI Resumes BioCryst Pharma (BCRX) at Outperform, Adds to Core SMID list
Tweet Send to a Friend
(Updated - February 18, 2026 8:18 AM EST)
Evercore ISI analyst Gavin Clark-Gartner resumes coverage on BioCryst Pharma (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Evercore ISI analyst Gavin Clark-Gartner resumes coverage on BioCryst Pharma (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
